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Abstract
Background: Reports of declining incidence of malaria disease burden across several countries in Africa suggest
that the epidemiology of malaria across the continent is in transition. Whether this transition is directly related to
the scaling of intervention coverage remains a moot point.
Methods: Paediatric admission data from eight Kenyan hospitals and their catchments have been assembled
across two three-year time periods: September 2003 to August 2006 (pre-scaled intervention) and September 2006
to August 2009 (post-scaled intervention). Interrupted time series (ITS) models were developed adjusting for
variations in rainfall and hospital use by surrounding communities to show changes in malaria hospitalization over
the two periods. The temporal changes in factors that might explain changes in disease incidence were examined
sequentially for each hospital setting, compared between hospital settings and ranked according to plausible
explanatory factors.
Results: In six out of eight sites there was a decline in Malaria admission rates with declines between 18% and
69%. At two sites malaria admissions rates increased by 55% and 35%. Results from the ITS models indicate that
before scaled intervention in September 2006, there was a significant month-to-month decline in the mean malaria
admission rates at four hospitals (trend P < 0.05). At the point of scaled intervention, the estimated mean
admission rates for malaria was significantly less at four sites compared to the pre-scaled period baseline.
Following scaled intervention there was a significant change in the month-to-month trend in the mean malaria
admission rates in some but not all of the sites. Plausibility assessment of possible drivers of change pre- versus
post-scaled intervention showed inconsistent patterns however, allowing for the increase in rainfall in the second
period, there is a suggestion that starting transmission intensity and the scale of change in ITN coverage might
explain some but not all of the variation in effect size. At most sites where declines between observation periods
were documented admission rates were changing before free mass ITN distribution and prior to the
implementation of ACT across Kenya.
Conclusion: This study provides evidence of significant within and between location heterogeneity in temporal
trends of malaria disease burden. Plausible drivers for changing disease incidence suggest a complex combination
of mechanisms, not easily measured retrospectively.
Background
Reports of declining incidence of malaria hospitalization,
deaths and prevalence in several, diverse areas of Africa
suggest that the epidemiology of malaria is in transition
across the continent [1-17]. This transition has been
coincidental with the scaling of intervention coverage
and increased international funding for the control of
malaria. However, precise attribution to intervention
coverage alone remains circumstantial, not least because
at most sites where declining disease incidence and pre-
valence have been reported, declines started before sig-
nificant increase in donor assistance and scaled
intervention coverage [2,8,9,12-14].
Adjusted trends in inpatient paediatric malaria case
burden over 10 years in a sample of 17 hospitals with
varied malaria transmission ecologies across Kenya were
recently described using population-adjusted clinical
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results showed divergent temporal patterns of disease
incidence between sites. Importantly these data signalled
that all was not equal across a single country. Here the
possible mechanisms underlying the differences between
these sites are explored in more detail in an effort to
explain plausible drivers for changing disease incidence.
Methods and Results
Overview of sample selection, time-periods and
methodological approach
For the purposes of evaluating mechanisms for change,
hospital settings with adequate temporal data on insecti-
cide-treated net (ITN) coverage (intervention change)
and parasite prevalence (transmission intensity change)
within defined spatial areas around hospitals that serve
as the catchment to these hospitals were selected. Of
the 17 original hospital settings the final selection of
eight hospitals covered the dominant malaria ecologies
that characterize Kenya including: three hospitals Bun-
goma, Kisumu, and Siaya District General Hospitals
(DGH) in the Western/lakeside high transmission areas;
Kericho and Kisii DGH located in the Highlands with
typically epidemic transmission; and the three sites in
Coastal Kenya: Malindi, Kilifi and Msambweni DGH.
Data have been assembled across two three-year time
periods: September 2003 to August 2006 and September
2006 to August 2009: corresponding to important time-
lines for malaria intervention and drug policy change in
Kenya. A range of plausible drivers and effect modifiers
of changes in disease incidence were identified including
intervention coverage, rainfall, service use and malaria
transmission intensity. These data have been assembled
at different spatial resolutions to match the communities
served by the hospitals used to define disease incidence.
Defining attribution is fraught with many challenges
and “plausibility designs” are often regarded as the only
feasible option to evaluate the impact of nationally pro-
moted large-scale intervention or changing risks [18,19].
These approaches have been recently promoted as a
means of examining changes consequent upon scaled
malaria control effort in sub-Saharan Africa [20]. Initi-
ally, temporal changes in factors that might explain
changes in disease incidence were sequentially examined
for each hospital setting, and were compared between
hospital settings and plausible explanatory factors were
ranked relative to proportional changes in disease inci-
dence. An analytical procedure called intervention ana-
lysis was then used, this allows some exogenous event,
in this case increasing ownership of ITNs and or a
change in the first-line treatment policy to ACT, to
occur that would affect the behaviour of the time-series
of disease incidence being modelled as an ARMA pro-
cess using the segmented regression [21,22].
Defining the geographic scope of attribute data - hospital
catchment populations
High resolution census data were used to produce popu-
lation distribution estimates around each hospital and
combined with a random sample of admissions where
residence was defined to compute distance travelled
from their homes to the hospital. Thematic maps were
created in ARCGIS 9.1 (ESRI, Inc., Redland, CA, USA)
and used to define a minimum catchment of census
bureau enumeration areas (EA) that would capture
more than 90% of all admissions to the paediatric wards
of each hospital [17]. Population counts in each EA
where then projected from the 1999 census using
growth rate curves and corrected for the proportion of
the population aged less than 15 years [23]. The 0-14
year projected population estimates were used to com-
pute the person-years-at-risk (PYAR) for the mid years
2004/5 and 2007/8 to estimate PYAR in the 2003-2006
and 2006-2009 periods respectively.
Paediatric admission data
Inpatient hospital registers were arranged serially to
represent a continuous, uninterrupted series. Each
admission entry in the registers was recorded on a tally
sheet indicating the month of admission, whether a pri-
mary working diagnosis of malaria was assigned to the
child and whether the child was aged less than 15 years.
Admissions without a diagnosis of malaria were coded
similarly. In six hospitals, slide-confirmed malaria diag-
noses at admission were not universally available within
and between hospital sites for the surveillance period,
however most admissions are likely to have a blood film
prepared pre-admission, but the parasitological results
could not be linked to patient records or registers and
this continues to pose a significant information gap.
Therefore our working definitions of “malaria” were
patients admitted with a diagnosis of malaria, probably
managed clinically as malaria during their admission but
without documented parasitological confirmation. At
Siaya and Kilifi DGHs a more detailed clinical admission
criteria have been used since 2003 and described
elsewhere [24-26]. Data were missing for two months
(September & October 2003) at Bungoma and admission
numbers were modeled in STATA (version 10.1) by
creating multiple imputed data sets for missing values
using other existing variables (rainfall and the number
of malaria and non-malaria deaths) for these missing
data [17]. Malaria and non-malaria incidence was com-
puted using the estimated children aged 0-14 years resi-
dent in the hospital catchment area and annualized over
three years for the “baseline”, pre-scaled intervention
period September 2003-August 2006 and post-scaled
intervention period September 2006-August 2009.
Monthly malaria and non-malaria incidence rates were
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mated annual proportion of the population aged less
than 15 years.
An ARMAX model was then applied [21] with changes
in service use (captured by non-malaria admission rates)
included as an explanatory variable resulting in a pre-
dicted or smoothed malaria admission rate per month for
each hospital site over the period 2003 to 2009 (Figure 1).
The ARMAX model was then extended to include an
interruption in the series to identify permanent changes
in the level of the disease incidence series (interrupted
time series analysis; ITS), that fits a linear regression to
each segment, pre- and post- period of scaled interven-
tion. The model is structured to identify changes in the
level of the series [21,22,27], with intervention times
entered as explanatory variables in the model. We have
used an exact intervention time point corresponding to
the intersection between the two time periods described
above. Segmented regression analyses were then used to
estimate the relative change in malaria admissions after
scaled intervention compared with before, taking into
account pre-ITN malaria admissions and trend fitting
different means for each period.
During the six years of surveillance there were a total
of 166,632 paediatric admissions including 78,530 (47%)
admissions where a diagnosis included malaria. The pro-
portion of admissions attributed to malaria across the
entire surveillance period varied from 70% in Western/
lakeside, 45% in the Highlands and 22% along the
Kenyan Coast (Table 1).
The annualized rate of paediatric malaria admission
declined in the second observation period compared to
the first at three locations on the coast (Table 1); the
absolute decline (expressed as the incidence rate differ-
ence of malaria per 1000 between the periods 2003-2006
and 2006-2009) was greatest in Malindi (-5.07) and low-
est in Msambweni (-0.82). These are equivalent to
decline of 69% in Kilifi, 61% in Malindi to the smallest
drop at 18% in Msambweni (Table 1; incidence rate ratio
(IRR)). Reductions in the second period compared to the
first were also observed for the two sites in the highlands
Kericho (-4.30) and Kisii (-10.85) and one urban site
close to Lake Victoria, Kisumu (-9.08) (Table 1). Conver-
sely, malaria admissions rates increased by 55% and 35%
at Bungoma and Siaya respectively (IRR; Table 1). The
incidence rate differences per 1000 children 0-14
between the periods 2003-2006 and 2006-2009 in non-
malaria admission rates were minimal at all sites except
Malindi and Msambweni where the differences were 1.9
and 1.78, respectively (incidence rate difference; Table 1).
The relationship between malaria admissions by month
shows declines in Kilifi, Malindi, Msambweni, Kisii, Keri-
cho and only in the first period in Kisumu (Figure 1).
Importantly the time trends show that the declines started
before scaled intervention in Kilifi, Malindi, Kisii, Kericho
and Kisumu. This appears less clear in Msambweni. Con-
versely the trend in malaria admission rates showed a rise
at Bungoma and Siaya with a rise in cases occurring
largely in 2008 and 2009. At Kisumu, somewhat of an out-
lier, following the decline in the first period there was a
rise in malaria admission rates in the second period occur-
ring in 2009 (Figure 1). Results from the interrupted time
series analysis indicate that just before the beginning of
the observation period, malaria admission rates on average
were between 2.21 to 12.5 per 1000 children 0-14 per
month (mean 6.30). Before September 2006, there was a
significant month-to-month change in the mean number
of malaria admission rates in Kisumu, Kilifi, Malindi and
Msambweni with a significant downward trend (P-value
for baseline trend <0.05) (Table 2). Immediately after the
scaled-intervention, the estimated mean admission rates
for malaria was significantly less by 0.52, 0.59, and 0.13 in
Kisumu, Kisii and Msambweni but were not significant at
the other sites. There was no significant change in the
month-to-month trend in the mean admission rates for
malaria across most of the hospitals except in Bungoma,
Siaya , Kisumu and Msambweni where the month-to-
month trend in the mean malaria admission rates
increased significantly in the second period (P-value for
trend change <0.05) (Table 2).
Rainfall
To examine the effects of rainfall, an important determi-
nant of malaria transmission, monthly precipitation data
were obtained from meteorological stations located
within the catchment areas of six hospitals. Because
records were incomplete or unavailable, rainfall data was
obtained from the nearest possible metrological station
with complete data for Msambweni, Bungoma, Kilifi and
Siaya (32 km to 70 km from the catchment boundary
respectively). Continuous mean monthly and annual
rainfall and the number of months in a year with rainfall
>80 mm or >60 mm among other variables were exam-
ined. There was an increasing trend toward higher
annual precipitation in the second observation period
(2006-2009) compared to the first observation period
(2003-2006). Between September 2006 and August 2009,
the mean monthly rainfall in seven out of the eight
study sites was higher on average than the three years
prior to this period (Table 3 and 4). The mean differ-
ence in average monthly rainfall between the first and
second observation periods was 19.5 mm (median 19.2;
IQR 11.2-25.9). In addition, the number of three-month
periods of continuous rainfall above 60 mm indicates
that the period before 2006 was notably drier than the
period after 2006 (Additional file 1 Table S1).
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Page 3 of 13Figure 1 Graph panels show changing paediatric hospitalizations rates due to malaria per 1 000 children 0-14 years before and after
scaling up of interventions. The data represents paediatric malaria admission rates by month (black solid line); model predictions of paediatric
malaria hospitalization rates controlling for non-malaria case rates, rainfall and controlling for autoregressive and moving average effects (dashed
blue line). Fitted lines illustrate the linear trends from model predictions (dashed line) for each segment of the period separated by a break point
(red dashed vertical line).
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One of the most widely used measures of Plasmodium
falciparum malaria transmission intensity is the parasite
rate (PfPR) measured through community-based surveys
and expressed as the proportion of people infected at
one point in time. A comprehensive dataset has been
assembled of all geo-located PfPR survey data
undertaken in Kenya since 1974 [28]. These data have
been re-sampled to identify surveys undertaken within
each hospital catchment, between 2002 and 2010 where
more than 50 people had been surveyed. The age-ranges
reported varied between surveys and these were stan-
dardized to a single age range 2-10 years (PfPR2-10)
using algorithms described elsewhere [29]. The
Table 1 Temporally aggregated paediatric admission data for malaria each of the 8 hospitals between 2003- 2006 and
2006-2009 expressed per 1000 children aged 0-14 years at risk per annum and 95% confidence intervals computed
using a Poisson distribution
Hospital
location
Average malaria
admission rate/1000
Sep 2003 - Aug 2006
[95% CI] (number of
malaria admissions)
Average malaria
admission rate/1000
Sep 2006 - Aug 2009
[95% CI] (number of
malaria admissions)
Inc Rate
Ratio (95%
CI) [Inc
Rate Diff ]
(95% CI)
Average non-malaria
admission rate/1000 Sep
2003 - Aug 2006 [95%
CI] (number of non-
malaria admissions)
Average nonmalaria
admission rate/1000 Sep
2006 - Aug 2009 [95%
CI] (number of non-
malaria admissions)
Inc Rate
Ratio (95%
CI) [Inc
Rate Diff ]
(95% CI)
Western/Lakeside
Bungoma
DGH
4.66
[4.53-4.79]
(4,853)
7.21
[7.06-7.37]
(8,500)
1.55
(1.50-1.61)
[2.56] (2.36-
2.76)
3.63
[3.52-3.75]
(3,783)
3.45
[3.34-3.56]
(4,063)
0.95
(0.91-0.99)
[-0.19]
(-0.34-
-0.03)
Kisumu
DGH
15.89
[15.61-16.18]
(12,128)
6.81
[6.64-6.99]
(5,578)
0.43
(0.42-0.44)
[-9.08]
(-9.41-
-8.74)
3.28
[3.15-3.41]
(2,501)
3.28
[3.16-3.41]
(2,685)
1.00
(0.95-1.06)
[0.00]
(-0.18- 0.18)
Siaya
DGH
14.93
[14.52-15.35]
(5,042)
20.12
[19.65-20.60]
(6,982)
1.35
(1.30-1.40)
[5.19]
(4.56-5.82)
8.10
[7.80-8.41]
(2,736)
7.22
[6.94-7.51]
(2,506)
0.89
(0.84-0.94)
[-0.88]
(-1.30-
-0.47)
Highlands
Kericho
DGH
9.80
[9.55-10.05]
5,923
5.50
[5.32-5.68]
(3,580)
0.56
(0.54-0.59)
[-4.30]
(-4.30-
-3.99)
7.21
7.00-7.43
4,360
6.58
[6.38-6.78]
(4,281)
0.91
(0.87-0.95)
[-0.64]
(-0.93-
-0.35)
Kisii
DGH
17.45
[17.12-17.79]
(10,450)
6.60
[6.40-6.80]
(4,201)
0.38
(0.36- 0.39)
[-10.85]
(-11.24-
-10.46)
16.67
[16.35-17.00]
(9,983)
17.28
[16.95-17.60]
(10,995)
1.04
(1.01-1.06)
[0.60]
(0.15-1.06)
Coastal
Kilifi
DGH
5.98
[5.78-6.18]
(3,345)
1.85
[1.75-1.97]
(1,139)
0.31
(0.29-0.33)
[-4.12]
(-4.35-
-3.89)
19.61
[19.24-19.98]
10,974
19.10
[18.75-19.45]
(11,730)
0.97
(0.95-1.00)
[-0.51]
(-1.01-
-0.00)
Malindi
DGH
8.28
[7.96-8.61]
(2,573)
3.21
[3.03-3.41]
(1,105)
0.39
(0.36-0.42)
[-5.07]
(-5.44-
-4.70)
18.76
[18.28-19.25]
5,828
16.88
[16.45-17.32]
(5,807)
0.90
(0.87-0.93)
[-1.88]
(-2.53-
-1.23)
Msambweni
DGH
4.74
[4.51-4.97]
(1,655)
3.91
[3.71-4.12]
(1,476)
0.82
(0.77-0.89)
[-0.83]
(-1.13-
-0.53)
7.15
[6.88-7.44]
2,498
8.93
[8.63-9.24]
(3,372)
1.25
(1.19-1.32)
[1.78]
(1.37-2.19)
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summarized using the median and inter-quartile ranges
of age standardized prevalence estimates (Pf PR2-10)
across the 300 surveys identified as having been under-
taken within the catchment areas since 2002 (Additional
file 1 Table S2).
During the first observation period, before scaled
intervention coverage in September 2006, the median
PfPR2-10 was highest around Lake Victoria. At Kisumu
median PfPR2-10 was 71% and around Siaya DGH PfPR2-
10 was 55% (Table 3), however it was reportedly lower
in Bungoma during this period (median Pf PR2-10,1 5 % ;
Table 3). In the highlands median PfPR2-10 was 22% at
Kisii and 5% at Kericho (Table 3). Along the Kenyan
coast median PfPR2-10 was between 10 and 13% during
the first, pre-scaled intervention period (Table 3). By the
second period (2006-2009) median PfPR2-10 had
declined in six out of the eight sites, this decline varied
between sites (Table 4) and the median PfPR2-10 had
increased to over 45% at Bungoma and rose slightly at
Msambweni from 10% to 12% (Table 4). During the sec-
ond observation period two hospital catchment areas
had a median PfPR2-10 of greater than 40%: Bungoma
and Siaya (Table 4).
Table 2 Parameter estimates, confidence intervals and P-values from the full segmented ARMAX regression models
predicting mean monthly numbers of malaria cases per month in eight hospitals over time
Mean before scale up Baseline trend Mean after scale up Trend change after scale up
Western/Lakeside
Coefficient 2.2189 -0.0038 -0.0797 0.0251
Bungoma DGH 95% CI -5.8433 - -0.0185 - -0.4578 - 0.0043 -
P-value 0.2811 0.0109 0.2985 0.0459
0.5900 0.6100 0.680 0.018
12.5782 -0.0213 -0.5247 0.0292
Kisumu DGH Coefficient 5.7537 - -0.0341 - - -0.8117 - - 0.0062 -
95% CI 19.4028 0.0086 0.2377 0.0521
P-value 0.000 0.001 0.000 0.013
7.3604 -0.0125 -0.1275 0.0557
Siaya DGH Coefficient -7.9641 - -0.0405 - -0.9069 - 0.0138 -
95% CI 22.6849 0.0156 0.6519 0.0975
P-value 0.347 0.384 0.749 0.009
Highlands
2.9036 -0.0043 -0.1847 -0.0014
Kericho DGH Coefficient -3.1163 - -0.0156 - -0.5648 - -0.0210 -
95% CI 8.9234 0.0070 0.1954 0.0182
P-value 0.344 0.457 0.341 0.888
6.10113 -0.00892 -0.59444 0.00019
Kisii DGH Coefficient -0.3973 - -0.0209 - -1.0789 - - -0.0148 -
95% CI 12.5996 0.0031 0.1100 0.0152
P-value 0.066 0.146 0.016 0.980
Coastal
7.2789 -0.0131 -0.0382 0.0094
Kilifi DGH Coefficient 3.3066 - -0.0207 - - -0.3036 - -0.0069 -
95% CI 11.2512 0.0056 0.2272 0.0256
P-value 0.000 0.001 0.778 0.260
7.6455 -0.0134 -0.0587 0.0072
Malindi DGH Coefficient 2.6559 - -0.0229 - - -0.3656 - -0.0111 -
95% CI 12.6351 0.0040 0.2483 0.0255
P-value 0.003 0.005 0.708 0.441
Coefficient 4.3503 -0.0078 -0.1287 0.0143
Msambweni DGH 95% CI 2.7546 - -0.0108 - - -0.2452 - - 0.0080 -
P-value 5.9459 0.0048 0.0122 0.0206
0.000 0.000 0.030 0.000
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In 2001, the Kenyan Government adopted a policy on
ITN to ensure 60% coverage by 2010 [30]. The domi-
nant ITN delivery approach between 2003 and Septem-
ber 2006 was a combined full cost recovery retail sector
promotion and subsidized cost ITN distribution using
social marketing at rural clinics [31]. In 2006 the Minis-
try of Health, using funds from the Global Fund,
launched a large-scale distribution campaign of free ITN
to children under the age of five years, which was com-
pleted in September 2006 and rapidly increased equita-
ble coverage of ITN nationwide [31]. Various household
survey data have been collected in Kenya since 2003
aimed at defining the proportion of children below the
age of five sleeping under an ITN during the night
before the survey. Cluster level data congruent with the
catchment areas defined for each of the eight hospitals
were re-sampled from the national Demographic and
Health Survey (DHS) undertaken in 2003 [32], Popula-
tion Services International household sample surveys
undertaken in 2005 and 2007 [33] and a national
malaria indicator survey [34] undertaken in 2007. Each
cluster was allocated to a time-period and data summed
across clusters within each catchment. During the 2003
DHS survey only data on children was available but sub-
sequent surveys included information on all age-groups
and have therefore focussed on all-age use of ITN for
comparisons between first and second observation
periods.
During the first observation period bed net use by
children aged less than five was universally low, the
highest average coverage in 2003 was recorded in
Kisumu (0.29%). The average level of coverage across all
eight sites was 20.3% in 2005 with the lowest level of
coverage recorded in Malindi at 9%, in Kericho and
Msambweni coverage was 14% and 15% respectively
while the highest estimated level of coverage was in
Kisii at 37%. By 2007, one year after the free mass distri-
bution campaigns ITN coverage had increased consider-
ably to an estimated average coverage of 41% across all
sites ranging from lowest coverage in Kericho at 32% to
high of 50% in Malindi and 51% in Kisii. The average
percentage increase was 21%, however at Bungoma,
Siaya, Kilifi and Kericho the increase in coverage was
less than 20% and remained below 40% in all 4 sites
including Msambweni during the post-scaled coverage
period (Additional file 1 Table S3).
Drug policy change and access to efficacious
antimalarials
Between 2000 and April 2006, sulphadoxine-pyrimetha-
mine (SP) was the only drug available in most
Table 3 Characteristics of Hospital Catchment areas 2003-2006
HOSPITAL Projected
Population
<15 years
in 2003
Average annual
number of Total
admissions
(2003 - 2006)
Average
annual
Rainfall (mm)
at Baseline
(2003-2006)
Median Age-
Corrected Parasite
Prevalence Jan
2002-Aug 2006
1
ITN
Coverage
SP Success
Rate
Average %
ACPR d14
(2000-
2003)
2
Number
reporting
fever in
last 14
days DHS
2003
3
Number (%) of
fevers seeking any
treatment from a
Public Health
Facility DHS 2003
3
Western/
Lakeside
Bungoma
DGH
326137 2879 1337.0 15.3% 20.5%
Kisumu DGH 245600 4876 1241.2 70.6% 26.2% 55.4-83.1 733
4 168(22.9)
4
Siaya DGH 111026 2593 1241.2 54.7% 21.0%
Highlands
Kericho DGH 194090 3428 2130.5 5.2% 14.3% 70.37 718
5 190(26.5)
5
Kisii DGH 193608 6811 1978.0 22.2% 35.6%
Coastal
Kilifi DGH 178045 4773 1136.0 12.9% 20.5%
Malindi DGH 98401 2800 954.7 11.8% 8.8% 67.2- 96.8 262 100(38.2)
Msambweni
DGH
111917 1384 588.7 10.4% 15.1%
Notes:
SP - Sulphadoxine-pyrimethamine ACPR - Acceptable Clinical & Parasitological Responses by day 14.
1Includes data from surveys done in 2002 and school surveys done in January and February 2010 in Bungoma, Kisumu, Siaya and Kericho areas.
2 Study references: [46]; [36,47].
3 Estimates reported at the Provincial level.
4Combined estimates from Western and Nyanza provinces.
5Combined estimates from Rift Valley and Nyanza provinces.
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Page 7 of 13government clinics [35] however, the efficacy of SP
declined rapidly over this period including empirical evi-
dence at some of the selected hospital sites that demon-
strated success rates of less than 75% by day 14
following treatment (Table 3, [36]; [37]). Officially first
line treatment policy was changed in April 2004 to the
more efficacious artemether-lumefathrine (AL) but the
new policy was not effectively implemented until Sep-
tember 2006 [38]. The clinical and parasitological effi-
cacy of AL was in excess of 94% in 2002-2003 at the
coast [39] and several clinical trials undertaken since
2006 have shown AL efficacy to be in excess of 87%.
Information on SP and AL sensitivity was attributed to
regions that broadly cover the catchments included in
the analysis but it was not possible to re-assemble these
data specifically to the communities served by the hospi-
tals (Table 3 and 4).
Prior to 2006 SP was ubiquitously available in govern-
ment facilities and through private retail providers
[35,38]. However, AL implementation in 2006 limited
access to only government and mission facilities [40]
and the supply to these facilities has been erratic and
incomplete [41]. Access to anti-malarials within 48
hours of onset of symptoms was generally poor across
Kenya throughout the period of observation 2003-2009.
At four sentinel districts (including Msambweni and
Kisii), Amin and colleagues showed that use of any anti-
malarial within 48 hours by febrile children was 15% in
2001 and 17% in 2006 [42]; unpublished data) and in
the same sites this rose to only 23% by 2007 [43].
Household survey data on drug use is much less proli-
f i ct h a nI T Nu s a g ed a t aa n d ,t h e r e f o r e ,i tw a so n l yp o s -
sible to assemble national survey data at wider spatial
resolutions than the catchment areas in the eight hospi-
tal sites. The respective provincial level data on treat-
ments with an anti-malarial for children who had a
reported fever in the last 14 days were assembled from
the DHS 2003 survey and the MIS in 2007 to represent
drug access in the two observation periods (Table 3 and
4). Between 2003 and 2006 the proportion of children
with fever in the last two weeks who sought treatment
from a Public Health Facility was estimated to be 23%
in Western/Lakeside region, 27% in the Highlands and
was highest at 38% on the Coast (Table 3). By the sec-
ond period, four years after the survey, access to treat-
ment had increased slightly across two study regions
with the proportion of fevers seeking treatment from a
Public Health Facility reported to be 31% in the Wes-
tern/Lakeside and 36% in the Highlands. However, on
Table 4 Characteristics of Hospital Catchment areas 2006-2009
HOSPITAL Projected
Population
<15 years
in 2003
Average annual
number of Total
admissions (2003 -
2006)
Average
annual
Rainfall
(mm) at
Baseline
(2003-2006)
Median Age-
Corrected Parasite
Prevalence Jan
2002-Aug 2006
1
ITN
Coverage
SP Success
Rate
Average %
ACPR d14
(2000-
2003)
2
Number
reporting
fever in
last 14
days DHS
2003
3
Number (%) of
fevers seeking any
treatment from a
Public Health
Facility DHS 2003
3
Western/
Lakeside
Bungoma
DGH
417832 4188 1673.3 44.9% 36.0%
Kisumu DGH 282645 2754 1472.1 29.8% 47.3% 93.4- 100.0 686
4 210 (30.6)
4
Siaya DGH 111026 2593 1241.2 54.7% 21.0%
Highlands
Kericho DGH 225159 2620 2095.4 0.01% 32.0% N/A 205
5 205 (35.7)
5
Kisii DGH 218698 5065 2063.0 1.9% 51.1%
Coastal
Kilifi DGH 214441 4290 1388.6 3.7% 38.1%
Malindi DGH 120658 2304 1145.6 4.5% 49.9% 87.0- 100.0 173 64 (37.0)
Msambweni
DGH
111917 1384 588.7 10.4% 15.1%
Notes:
AL - Artmether-lumefathrine.
ACPR - Acceptable Clinical & Parasitological Responses. Day 28 PCR corrected parasitological and clinical failure rates.
1Includes data from school surveys done in January and February 2010 in Bungoma, Kisumu, Siaya and Kericho areas.
2Study references: [48-53].
3Estimates reported at the Provincial level. These data were available at the provincial level and not specific to each district or catchment area and are presented as
such.
4Combined estimates from Western and Nyanza provinces.
5Combined estimates from Rift Valley and Nyanza provinces.
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Page 8 of 13Coast access to treatment has remained largely
unchanged at 37% in 2007 (Table 4).
Comparison of health indictors pre- and post 2006
The surveillance data were analysed by time to deter-
mine whether patterns in hospitalized malaria case inci-
dence could be associated to equivalent changes in
several important covariates. Outcome indicators are
summarized as incidence rate ratios and incidence rate
differences based on admission events with mid-period
under 15 population estimates as the denominator. The
relative change and the absolute changes (95% CI) in
covariates between period 1 and 2 calculated for each
hospital were used as the comparative measures. The
absolute change is used to describe the actual increase
or decrease from the estimate in period one and is used
to explore the magnitude of change. Relative change is
used to describe changes between period one and two
by comparing the absolute change to the reference value
which here is the value of the estimate in the first per-
iod and has been used here to explore processes of cau-
sation specifically to examine the effect of changes in
intervention coverage or climate variables on the occur-
rence of malaria cases. We examine changes in relation
to the starting endemicity and baseline ITN coverage for
the parasite prevalence and ITN coverage respectively.
Plausibility patterns exploring factors that might
explain changes in disease incidence across hospital
settings represented by different colors are shown in
Figures 2 and 3. Patterns in IRR (x-axis) were examined
against parasite prevalence in the first and second per-
iod, the absolute change in prevalence, ITN coverage in
the second period and the absolute change in ITN cov-
erage (x-axis). No obvious patterns were clearly evident
however, considering that rainfall increased during the
same period, out of all the factors we have examined,
there is a suggestion that sustained high transmission
intensity in the second period (Figure 2; middle graph)
and the magnitude of change in ITN coverage (Figure 3;
right graph) might explain some of the variation in
effect size.
In addition, the combined effect of various factors
were examined using the ranking of plausible explana-
tory factors (ranked by magnitude) with 1 representing
the highest score/change and 8 the lowest score/change
relative to the ranking of the effect size represented as
the absolute change in disease incidence in each hospital
site (Table 5). Despite the fact that the ranking shows
largely ambiguous patterns; there is some indication that
transmission intensity reduced to low levels in the sites
that witnessed a substantial drop in malaria hospitaliza-
tion (ranking 1-5) with the exception of Kisumu and
Msambweni (Table 3 and 4). The ranking tables also
showed that the two sites with a rise in malaria
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Figure 2 Relationship between changes in the incidence rate
of malaria admissions between period one and two (Incidence
rate ratio) and equivalent absoulte changes in transmission
intensity across 8 hospital sites in Kenya (Left-starting PfPR;
Middle - PfPR at the end of the study and Right - absolute
difference in prevalence between period one and two).
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Page 9 of 13hospitalization appear to have the highest transmission
intensity in the second period (ranked 1 and 2); (Table
5). Kisii which had the highest absolute drop in malaria
admission rates also had the highest level of ITN cover-
a g ei np e r i o dt w oa n das i g n i f i c a n td r o pi nPfPR2-10
(ranked 2).
Discussion
The temporal patterns of paeditaric malaria admissions
at eight hospitals across the diverse malaria transmission
ecology of Kenya were examined between two 36 month
periods September 2003 and August 2009 and the period
September 2006 to August 2009 representing two periods
best described as reflecting major shifts in intervention
policy change and scaled intervention. At six hospital
sites (Kisumu, Kericho, Kisii, Kilifi, Malindi and Msamb-
weni) hospitalization from malaria showed a significant
reduction between these two time periods (Table 1), but
in four cases the decline started before scaled interven-
tion (significant baseline downward trend in Kilifi, Mal-
indi Msambweni, and Kisumu, Table 2). Similar declines
were observed at Msambweni on the southernmost tip of
the Kenyan coast but these declines were less marked.
Kisumu represents an outlier where despite the fact that
there was a significant drop in malaria cases between per-
iod one and two hospitalization from malaria showed a
significant upward trend in period two. At Siaya and
Bungoma paediatric malaria admission rates rose in the
second period compared to the pre-scaled intervention
period before September 2006. It is important to
acknowledge that the majority of the data analyzed here
are not based upon parasitological confirmed cases of
malaria as these data were often not available and of vari-
able quality and accuracy and may have contributed to
some systematic bias in the data and remains an inherent
methodological limitation.
A number of extrinsic (rainfall), biological (transmis-
sion intensity) and intervention (ITN coverage and ACT
access) that may have explained the changes in the
interupted time-series of paediatric malaria admissions
were examined. Rainfall proved not to explain any of
the changes directly as the second observation period
was wetter than the first at all sites where declines
occurred and changes in rainfall patterns were not dif-
ferent between sites with increasing malaria admissions
compared to those without (Table 3 and 4). Parasite
prevalence during the period prior to scaled intervention
among communities located within the catchments of
the hospitals signalled that there was some tendency for
those areas that showed the largest declines in admis-
sion rates in post-intervention to be of lowest
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Figure 3 Relationship between changes in the incidence rate
of malaria admissions between period one and two (Incidence
rate ratio) and equivalent absolute changes in ITN coverage
across 8 hospital catchments (Left- absolute difference in ITN
coverage between period one and two; Right - ITN coverage in
the follow-up period).
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Page 10 of 13transmission intensity in the period prior to scaled
intervention for some but not all of the sites. For exam-
p l eB u n g o m aa n dK i s u m uw e r er a n k e dl o wa n dh i g h
PfPR2-10 in the first observation period. Theoretically it
has been suggested that scaled intervention coverage
with ITN is least likely to impact on disease incidence
where starting transmission intensity is highest [44].
These data do not rule out this possibility with largest
differences observed in admission rates among areas
where starting PfPR2-10 was low but this trend was not
c o n s i s t e n ta c r o s st h ee i g h ts i t e s( T a b l e3 ;F i g u r e2 ) .I t
was not possible to re-assemble spatially congruent data
on drug sensitivity and drug access as a driver of tem-
poral changes in disease incidence; nevertheless the data
d os h o wam a r g i n a li n c r e a s ei nt h eu s eo fp u b l i ch e a l t h
services between the two observation periods but must
be balanced with the periennial problems of poor drug
availability in this sector. It seems unlikely that changing
to an ACT policy in September 2006 would have been a
major factor in the changing incidence of malaria
admissions. However, it was possible to re-construct
site-specific data on ITN coverage and the changes in
population coverage with an ITN were dramatic
between the two observation periods (Tables 3 and 4).
The absolute decline in malaria admission rates was
highest in the three areas where post-scaled ITN cover-
age was highest (Table 3: Kisii, Kisumu and Malindi)
and two of these sites also showed the highest declines
in PfPR2-10 (Table 3: Kisii and Kisumu). Two areas
where ITN coverage remained poor post-September
2006 were Bungoma and Siaya where malaria
admissions increased. These observations at these sites
are largely consistent with expectations [45], but there
were also anomalies to this observed pattern. These
anomalies do not imply that increased ITN coverage has
not impacted on disease incidence rather that the expla-
nations for temporal changes in admissions are complex
and unlikely to be a result of ITN alone.
Conclusions
Support for the complex nature of change derives from
the observation that most sites where declines between
observation periods were observed showed evidence of
changing admission rates ahead of the free mass ITN
distribution campaign and prior to the implementation
of ACT across Kenya. What then are the drivers of this
epidemiological transition? In this paper an attempt was
made to retrospectively assemble as much information
as possible to develop a plausibility framework around
an interrupted time-series data analysis. The conclusion
is that although there have been changes, this has not
been consistent across sites, both starting endemicity
and ITN coverage may have accelerated declines but it
is not possible to confidently identify unique factors
associated with the trend in malaria admissions. In part
this may well stem from having to depend on retrospec-
tive, opportunistic data assemblies to explain change.
This is an unfortunate position to be in and a lesson for
future monitoring and evaluation of epidemiological
transitions. Without more prospectively designed plausi-
bility studies with carefully assembled disease data con-
gruent with information on plausible explanatory
Table 5 Plausibility ranking table indicating the ranking of each hospital by absolute change in several important
factors
Rank by Covariates
Absolute
Change in
Incidence
Parasite Prevalence ITN Coverage Rainfall
Rank
by
IRD
PfPR2-10
2003
-2006
PfPR2-10
2006-
2009
Change
in PfPR2-
10
ITN
coverage
2006- 2009
Change in
ITN
coverage
Change in 3 Continuous
months with RF >60
mm
Change
in Total
RF
Change in
mean
monthly RF
Kisii (-10.85) 1 3 7 2 1 7 8 77
Kisumu (-9.08) 2 1 3 1 3 3 2 4 4
Malindi (-5.07) 3 6 5 4 2 1 1 6 6
Kericho (-4.30) 4 8 8 6 8 5 6 88
Kilifi (-4.12) 5 5 6 3 6 6 5 3 2
Msambweni
(-0.83)
67 4 7 52 6 2 3
Bungoma (2.56) 7 4 2 8 77 4 1 1
Siaya (5.19) 8 2 1 5 4 4 2 4 4
Notes:
IRD-Incidence Rate Difference.
1 = highest value/change 8 = smallest value/change.
Bold numbers represents instances where the observed trend is the reverse of the common trend i.e. an increase in transmission intensity (PfPR2-10 )o ra
reduction in rainfall.
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Page 11 of 13variables for change it may never be understood what is
driving the malaria transition in Africa.
Additional material
Additional file 1: Characteristics of hospital-catchment sites -
Changes in Plausibility Drivers. The data provided represent the
analysis of temporal changes in factors that might explain changes in
disease incidence in each hospital setting and compared between
hospital settings.
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